VERTEX PHARMACEUTICALS INC / MA Quarterly Current Ratio in % from Q4 2010 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Current Ratio history and growth rate from Q4 2010 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Current Ratio for the quarter ending September 30, 2024 was 311 %, a 27.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 311 -120 -27.8% Sep 30, 2024
Q2 2024 352 -93.8 -21% Jun 30, 2024
Q1 2024 392 -65.3 -14.3% Mar 31, 2024
Q4 2023 412 -57.9 -12.3% Dec 31, 2023
Q3 2023 431 -30 -6.51% Sep 30, 2023
Q2 2023 446 -11.8 -2.58% Jun 30, 2023
Q1 2023 457 -4.13 -0.9% Mar 31, 2023
Q4 2022 470 +17.7 +3.93% Dec 31, 2022
Q3 2022 461 +11.8 +2.63% Sep 30, 2022
Q2 2022 458 +32.8 +7.7% Jun 30, 2022
Q1 2022 461 +56.9 +14.1% Mar 31, 2022
Q4 2021 452 +67.7 +17.6% Dec 31, 2021
Q3 2021 449 +83 +22.7% Sep 30, 2021
Q2 2021 425 +66.6 +18.6% Jun 30, 2021
Q1 2021 404 +46.5 +13% Mar 31, 2021
Q4 2020 384 +20.8 +5.72% Dec 31, 2020
Q3 2020 366 +6.53 +1.82% Sep 30, 2020
Q2 2020 359 -8.03 -2.19% Jun 30, 2020
Q1 2020 358 -6.83 -1.87% Mar 31, 2020
Q4 2019 363 +1.94 +0.54% Dec 31, 2019
Q3 2019 359 -0.4 -0.11% Sep 30, 2019
Q2 2019 367 +17.6 +5.04% Jun 30, 2019
Q1 2019 365 +21.3 +6.22% Mar 31, 2019
Q4 2018 361 +18.5 +5.4% Dec 31, 2018
Q3 2018 360 +46.1 +14.7% Sep 30, 2018
Q2 2018 349 +68.4 +24.3% Jun 30, 2018
Q1 2018 343 +89.9 +35.5% Mar 31, 2018
Q4 2017 343 +113 +49% Dec 31, 2017
Q3 2017 314 +73.8 +30.7% Sep 30, 2017
Q2 2017 281 +7.25 +2.65% Jun 30, 2017
Q1 2017 253 -49 -16.2% Mar 31, 2017
Q4 2016 230 -118 -33.9% Dec 31, 2016
Q3 2016 240 -152 -38.8% Sep 30, 2016
Q2 2016 274 -139 -33.8% Jun 30, 2016
Q1 2016 302 -117 -28% Mar 31, 2016
Q4 2015 348 -56.5 -14% Dec 31, 2015
Q3 2015 392 -7.75 -1.94% Sep 30, 2015
Q2 2015 413 +23.3 +5.98% Jun 30, 2015
Q1 2015 420 +11.2 +2.75% Mar 31, 2015
Q4 2014 405 -3.82 -0.94% Dec 31, 2014
Q3 2014 399 -0.32 -0.08% Sep 30, 2014
Q2 2014 390 -9.88 -2.47% Jun 30, 2014
Q1 2014 409 +16.2 +4.13% Mar 31, 2014
Q4 2013 408 +11.5 +2.9% Dec 31, 2013
Q3 2013 400 +9.28 +2.38% Sep 30, 2013
Q2 2013 400 +65.4 +19.6% Jun 30, 2013
Q1 2013 392 +120 +44.1% Mar 31, 2013
Q4 2012 397 +164 +70.4% Dec 31, 2012
Q3 2012 390 +182 +87.2% Sep 30, 2012
Q2 2012 334 +97.3 +41.1% Jun 30, 2012
Q1 2012 272 -5.97 -2.15% Mar 31, 2012
Q4 2011 233 -109 -31.9% Dec 31, 2011
Q3 2011 209 Sep 30, 2011
Q2 2011 237 Jun 30, 2011
Q1 2011 278 Mar 31, 2011
Q4 2010 342 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.